Jeffrey M Rosen
Baylor College of Medicine
H-index: 99
North America-United States
Top articles of Jeffrey M Rosen
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract B047: Epigenetic reprogramming by CBP/P300 bromodomain inhibition of triple-negative breast cancer and the immune microenvironment | Cancer Research | Xueying Yuan Michael Soth Na Zhao Philip Jones Jeffrey Rosen | 2024/2/1 |
Abstract B012: Wnt/Ror2 signaling regulates myoepithelial cell fate and luminal cell proliferation during mammary development | Cancer Research | Hongjiang Si Jeffrey Rosen Chad Creighton Kevin Roarty | 2024/2/1 |
Abstract PR03: CSF-1R antibody targeting therapy with combined metronomic chemotherapy and immune checkpoint blockade enhance a B and T cell response to attenuate metastatic … | Cancer Research | Diego A Pedroza Qian Zhu Weigou Wu Paul Porter Xiang HF Zhang | 2024/2/1 |
Abstract IA05: Leveraging preclinical models of triple negative breast cancer for translational research | Cancer Research | Jeffrey M Rosen Diego Pedroza Na Zhao Xiang HF Zhang Charles M Perou | 2024/2/1 |
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC | bioRxiv | Xueying Yuan Xiaoxin Hao Hilda L Chan Na Zhao Diego A Pedroza | 2024 |
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer | The Journal of clinical investigation | Na Zhao Elena B Kabotyanski Alexander B Saltzman Anna Malovannaya Xueying Yuan | 2023/12/15 |
Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer | Cancer immunology research | Oluwatoyosi Adewunmi Yichao Shen Xiang H-F Zhang Jeffrey M Rosen | 2023/11/1 |
Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials | JAMA network open | Deborah A Theodore Angela R Branche Lily Zhang Daniel S Graciaa Madhu Choudhary | 2023/7/3 |
Tumor concentration of metformin is a determinant factor of its regulation of fatty acid β-oxidation and c-Src pathway in triple-negative breast cancer | Cancer Research | Junhyoung Park Kwang Hwa Jung Dongya Jia Sukjin Yang Kuldeep S Attri | 2023/4/4 |
Abstract PD2-05: CSF-1R antibody targeting therapy with combined metronomic chemotherapy enhances a B and T cell response for the treatment of metastatic triple negative breast … | Cancer Research | Diego Pedroza Weiguo Wu Paul Porter Xiang Zhang Jeffrey Rosen | 2023/3/1 |
Abstract P6-14-09: Non-canonical Wnt/Ror2 signaling regulates tumor cell invasion and dissemination in breast cancer through cell-matrix crosstalk | Cancer Research | Hongjiang Si Na Zhao Andrea Pedroza Chad Creighton Jeffrey Rosen | 2023/3/1 |
The tumor-immune ecosystem in shaping metastasis | Yang Gao Jeffrey M Rosen Xiang H-F Zhang | 2023/3/1 | |
LEF1 drives a central memory program and supports antitumor activity of natural killer T cells | Cancer immunology research | Ho Ngai Gabriel A Barragan Gengwen Tian Julien C Balzeau Chunchao Zhang | 2023/2/3 |
Noncanonical Wnt/Ror2 signaling regulates cell–matrix adhesion to prompt directional tumor cell invasion in breast cancer | Molecular Biology of the Cell | Hongjiang Si Na Zhao Andrea Pedroza Ana-Maria Zaske Jeffrey M Rosen | 2022/9/15 |
Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer | Cancer research | Swarnima Singh Nigel Lee Diego A Pedroza Igor L Bado Clark Hamor | 2022/6/15 |
A Highlights from MBoC Selection: Noncanonical Wnt/Ror2 signaling regulates cell–matrix adhesion to prompt directional tumor cell invasion in breast cancer | Molecular Biology of the Cell | Hongjiang Si Na Zhao Andrea Pedroza Ana-Maria Zaske Jeffrey M Rosen | 2022/9/9 |
Single-cell analysis unveils the role of the tumor immune microenvironment and notch signaling in dormant minimal residual disease | Cancer research | Mahnaz Janghorban Yuchen Yang Na Zhao Clark Hamor Tuan M Nguyen | 2022/3/1 |
Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies | Na Zhao Jeffrey M Rosen | 2022/7/1 | |
LncRNA MALAT1 as a potential therapeutic target in triple negative breast cancer | Cancer Research | Oluwatoyosi Adewunmi Jeffrey Rosen | 2022/6/15 |
Abstract B020: Reprogramming epithelial-mesenchymal transition and the immune microenvironment in triple-negative breast cancer with epigenetic drugs | Cancer Research | Xueying Yuan Michael Soth Philip Jones Jeffrey Rosen | 2022/12/1 |
